PEPTIDES 2017* Greg Bourne
Protagonist inc., QLD, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
PTG-100, an oral peptide antagonist of α4β7 integrin, for the treatment of inflammatory bowel disease (#63)
4:00 PM
Greg Bourne
Session 13 - Towards the Clinic